These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38353886)

  • 21. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.
    Seow KM; Chang YW; Chen KH; Juan CC; Huang CY; Lin LT; Tsui KH; Chen YJ; Lee WL; Wang PH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
    Łebkowska A; Adamska A; Krentowska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Hryniewicka J; Leśniewska M; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
    J Clin Endocrinol Metab; 2021 May; 106(6):1811-1820. PubMed ID: 33537700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes.
    García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A
    Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome and mitochondrial dysfunction.
    Zhang J; Bao Y; Zhou X; Zheng L
    Reprod Biol Endocrinol; 2019 Aug; 17(1):67. PubMed ID: 31420039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian functions and polycystic ovary syndrome in adult women with type 1 diabetes mellitus in a Turkish population.
    Urhan E; Elbuken G; Hacioglu A; Karaca Z; Unluhizarci K; Kelestimur F
    J Endocrinol Invest; 2023 Mar; 46(3):609-616. PubMed ID: 36308639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes: a metabolic and reproductive disorder in women.
    Thong EP; Codner E; Laven JSE; Teede H
    Lancet Diabetes Endocrinol; 2020 Feb; 8(2):134-149. PubMed ID: 31635966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Best methods for identification and treatment of PCOS.
    Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
    Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population-based study.
    Thong EP; Milat F; Joham AE; Mishra GD; Teede H
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):564-571. PubMed ID: 32640055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.
    Dunaif A
    Am J Med; 1995 Jan; 98(1A):33S-39S. PubMed ID: 7825639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
    Escobar-Morreale HF; Roldán B; Barrio R; Alonso M; Sancho J; de la Calle H; García-Robles R
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4182-7. PubMed ID: 11095451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome.
    Rezaee M; Asadi N; Pouralborz Y; Ghodrat M; Habibi S
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):562-566. PubMed ID: 27593259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between insulin resistance and abnormal menstrual cycle in Chinese patients with polycystic ovary syndrome.
    Niu J; Lu M; Liu B
    J Ovarian Res; 2023 Feb; 16(1):45. PubMed ID: 36823522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.